EPISODE · Feb 11, 2026 · 53 MIN
When a Common Fever Drug Changes Brain Development
from Demystifying PANS/PANDAS Podcast · host Nancy O'Hara MD
What if one of the most commonly used childhood medications carries risks that medicine has failed to fully confront? In this episode of Demystifying PANS/PANDAS, I speak with Dr. William Parker about decades of research connecting acetaminophen exposure, susceptibility, and neurodevelopment, and why timing, metabolism, and immune stress matter more than most studies acknowledge.One overlooked moment may explain far more about autism risk than decades of debate. On this episode of Demystifying PANS/PANDAS, I speak with Dr. William Parker about why acetaminophen exposure around the time of birth has emerged as a consistent trigger in susceptible children, and how metabolism, oxidative stress, and timing intersect in ways mainstream research often fails to address.We explore toxicology data, animal studies, cord blood findings, regressive autism patterns, and why adjusting out susceptibility leads to misleading conclusions. The conversation also examines fever suppression, immune stress, and how broader immune tolerance research helps explain why certain children are more vulnerable than others.Dr. William Parker is a biochemist and immunologist with nearly three decades of research experience in microbiology, neurodevelopment, and immune function. His work has focused on how environmental exposures interact with susceptibility to shape long-term health outcomes.He is widely known for his research on acetaminophen and neurodevelopment, the role of oxidative stress in autism spectrum disorder, and the function of the human appendix as a reservoir for beneficial gut bacteria. His work has been published in multiple peer-reviewed journals and continues to influence conversations around immune tolerance, inflammation, and pediatric care.Dr. William Parker Website: preventautism.orgNancy O’Hara, MD, MPH, FAAP, FMAPSWebsite: https://www.drohara.comFacebook: https://www.facebook.com/drnancyohara/Instagram: https://www.instagram.com/nhoharamd/LinkedIn: https://www.linkedin.com/in/nancy-o-hara-md-mph-faap-390781258/PODCASTThank you for listening.Please subscribe and share.This podcast is produced by DrTalks.comhttps://drtalks.com/podcast-service/
What this episode covers
What if one of the most commonly used childhood medications carries risks that medicine has failed to fully confront? In this episode of Demystifying PANS/PANDAS, I speak with Dr. William Parker about decades of research connecting acetaminophen exposure, susceptibility, and neurodevelopment, and why timing, metabolism, and immune stress matter more than most studies acknowledge.One overlooked moment may explain far more about autism risk than decades of debate. On this episode of Demystifying PANS/PANDAS, I speak with Dr. William Parker about why acetaminophen exposure around the time of birth has emerged as a consistent trigger in susceptible children, and how metabolism, oxidative stress, and timing intersect in ways mainstream research often fails to address.We explore toxicology data, animal studies, cord blood findings, regressive autism patterns, and why adjusting out susceptibility leads to misleading conclusions. The conversation also examines fever suppression, immune stress, and how broader immune tolerance research helps explain why certain children are more vulnerable than others.Dr. William Parker is a biochemist and immunologist with nearly three decades of research experience in microbiology, neurodevelopment, and immune function. His work has focused on how environmental exposures interact with susceptibility to shape long-term health outcomes.He is widely known for his research on acetaminophen and neurodevelopment, the role of oxidative stress in autism spectrum disorder, and the function of the human appendix as a reservoir for beneficial gut bacteria. His work has been published in multiple peer-reviewed journals and continues to influence conversations around immune tolerance, inflammation, and pediatric care.Dr. William Parker Website: preventautism.orgNancy O’Hara, MD, MPH, FAAP, FMAPSWebsite: https://www.drohara.comFacebook: https://www.facebook.com/drnancyohara/Instagram: https://www.instagram.com/nhoharamd/LinkedIn: https://www.linkedin.com/in/nancy-o-hara-md-mph-faap-390781258/PODCASTThank you for listening.Please subscribe and share.This podcast is produced by DrTalks.comhttps://drtalks.com/podcast-service/
NOW PLAYING
When a Common Fever Drug Changes Brain Development
No transcript for this episode yet
Similar Episodes
Mar 26, 2026 ·1m
Jan 2, 2026 ·47m
Dec 21, 2025 ·46m